ALMLB Fundamental Analysis - MILIBOO SA

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALMLB. ALMLB was compared to 33 industry peers in the Household Durables industry. The financial health of ALMLB is average, but there are quite some concerns on its profitability. ALMLB has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALMLB has reported negative net income.

ALMLB had a negative operating cash flow in the past year.

In multiple years ALMLB reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: ALMLB reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -1.61%, ALMLB is not doing good in the industry: 81.82% of the companies in the same industry are doing better.

ALMLB has a Return On Equity of -3.94%. This is amonst the worse of the industry: ALMLB underperforms 81.82% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-3.94%
ROIC	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALMLB (26.58%) is worse than 63.64% of its industry peers.

In the last couple of years the Gross Margin of ALMLB has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for ALMLB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	26.58%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALMLB remains at a similar level compared to 1 year ago.

The number of shares outstanding for ALMLB has been increased compared to 5 years ago.

Compared to 1 year ago, ALMLB has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.42 indicates that ALMLB is not in any danger for bankruptcy at the moment.

ALMLB has a Altman-Z score of 3.42. This is in the better half of the industry: ALMLB outperforms 78.79% of its industry peers.

ALMLB has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.15, ALMLB belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	3.42

ROIC/WACCN/A

WACC7.07%

2.3 Liquidity

A Current Ratio of 1.78 indicates that ALMLB should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.78, ALMLB is in the better half of the industry, outperforming 60.61% of the companies in the same industry.

A Quick Ratio of 0.85 indicates that ALMLB may have some problems paying its short term obligations.

ALMLB has a Quick ratio (0.85) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALMLB have decreased strongly by -110.80% in the last year.

ALMLB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.02%.

Measured over the past years, ALMLB shows a small growth in Revenue. The Revenue has been growing by 5.42% on average per year.

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.16%

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

3.2 Future

The Earnings Per Share is expected to decrease by -32.45% on average over the next years. This is quite bad

The Revenue is expected to decrease by -9.38% on average over the next years.

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-32.45%

EPS Next 5YN/A

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-9.38%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALMLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

ALMLB is valuated cheaply with a Price/Forward Earnings ratio of 5.23.

ALMLB's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALMLB is cheaper than 96.97% of the companies in the same industry.

ALMLB is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.89, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5.23

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALMLB indicates a slightly more expensive valuation: ALMLB is more expensive than 75.76% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2760.98

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALMLB's earnings are expected to decrease with -32.45% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.93%

EPS Next 3Y-32.45%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALMLB!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MILIBOO SA

EPA:ALMLB (9/26/2025, 7:00:00 PM)

1.63

+0.02 (+1.56%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners43%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap11.30M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5.23
P/S	0.29
P/FCF	N/A
P/OCF	N/A
P/B	1.73
P/tB	2.62
EV/EBITDA	2760.98

EPS(TTM)-0.04

EYN/A

EPS(NY)0.31

Fwd EY19.13%

FCF(TTM)-0.18

FCFYN/A

OCF(TTM)-0.06

OCFYN/A

SpS5.62

BVpS0.94

TBVpS0.62

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-3.94%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	26.58%
FCFM	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

F-Score2

Asset Turnover2.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	236.75
Cap/Depr	162.09%
Cap/Sales	2.15%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.78
Quick Ratio	0.85
Altman-Z	3.42

F-Score2

WACC7.07%

ROIC/WACCN/A

Cap/Depr(3y)200.54%

Cap/Depr(5y)208.68%

Cap/Sales(3y)2.1%

Cap/Sales(5y)2.06%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.16%

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-32.45%

EPS Next 5YN/A

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-9.38%

Revenue Next 5YN/A

EBIT growth 1Y-118.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.04%

EBIT Next 3Y-21.91%

EBIT Next 5YN/A

FCF growth 1Y-215.16%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-118.08%

OCF growth 3YN/A

OCF growth 5YN/A

MILIBOO SA (ALMLB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens